|
Volumn 345, Issue 6193, 2014, Pages 143-144
|
Persistence by proliferation?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRUS AGENT;
HIGH MOBILITY GROUP A2 PROTEIN;
MESSENGER RNA;
MICRORNA;
BACH2 PROTEIN, HUMAN;
BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR;
MKL2 PROTEIN, HUMAN;
TRANSCRIPTION FACTOR;
DISEASE TREATMENT;
DRUG;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNE SYSTEM;
PERSISTENCE;
CD4+ T LYMPHOCYTE;
CELL PROLIFERATION;
DISEASE ERADICATION;
GENETIC VARIABILITY;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
IMMUNE RESPONSE;
INFECTION CONTROL;
LONG TERM CARE;
LYMPHOMA;
MEMORY T LYMPHOCYTE;
MUTAGENESIS;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
T LYMPHOCYTE SUBPOPULATION;
VIREMIA;
VIRUS REPLICATION;
GENETICS;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NOTE;
PHYSIOLOGY;
VIROLOGY;
VIRUS DNA CELL DNA INTERACTION;
VIRUS LATENCY;
BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS;
HIV;
HIV INFECTIONS;
HUMANS;
TRANSCRIPTION FACTORS;
VIRUS INTEGRATION;
VIRUS LATENCY;
|
EID: 84904110055
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1257426 Document Type: Short Survey |
Times cited : (17)
|
References (15)
|